Efficacy and Safety of Lisdexamfetamine for Treatment of Adults With Moderate to Severe Binge-Eating Disorder | Zendy

Susan L. McElroy | Zendy; James I. Hudson | Zendy; James E. Mitchell | Zendy; Denise E. Wilfley | Zendy; M. Celeste FerreiraCornwell | Zendy; Joseph Gao | Zendy; Jiang Wang | Zendy; Timothy Whitaker | Zendy; Jeffrey M. Jonas | Zendy; Maria Gasior | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy and Safety of Lisdexamfetamine for Treatment of Adults With Moderate to Severe Binge-Eating Disorder

Author(s) -

Susan L. McElroy,

James I. Hudson,

James E. Mitchell,

Denise E. Wilfley,

M. Celeste FerreiraCornwell,

Joseph Gao,

Jiang Wang,

Timothy Whitaker,

Jeffrey M. Jonas,

Maria Gasior

Publication year - 2015

Publication title -

jama psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.531

H-Index - 365

eISSN - 2168-6238

pISSN - 2168-622X

DOI - 10.1001/jamapsychiatry.2014.2162

Subject(s) - placebo , dose , adverse effect , medicine , binge eating , weight change , binge drinking , binge eating disorder , anesthesia , obesity , psychiatry , poison control , weight loss , eating disorders , injury prevention , bulimia nervosa , alternative medicine , pathology , environmental health

Binge-eating disorder (BED), a public health problem associated with psychopathological symptoms and obesity and possibly with metabolic syndrome, lacks approved pharmacotherapies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research